These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 15671247)
1. AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factor-like domain-dependent manner. Felekkis KN; Narsimhan RP; Near R; Castro AF; Zheng Y; Quilliam LA; Lerner A Mol Cancer Res; 2005 Jan; 3(1):32-41. PubMed ID: 15671247 [TBL] [Abstract][Full Text] [Related]
2. Estradiol rapidly activates Akt via the ErbB2 signaling pathway. Stoica GE; Franke TF; Wellstein A; Czubayko F; List HJ; Reiter R; Morgan E; Martin MB; Stoica A Mol Endocrinol; 2003 May; 17(5):818-30. PubMed ID: 12554767 [TBL] [Abstract][Full Text] [Related]
3. AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter. Cai D; Iyer A; Felekkis KN; Near RI; Luo Z; Chernoff J; Albanese C; Pestell RG; Lerner A Cancer Res; 2003 Oct; 63(20):6802-8. PubMed ID: 14583477 [TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588 [TBL] [Abstract][Full Text] [Related]
5. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748 [TBL] [Abstract][Full Text] [Related]
6. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Kimura A; Ohmichi M; Kawagoe J; Kyo S; Mabuchi S; Takahashi T; Ohshima C; Arimoto-Ishida E; Nishio Y; Inoue M; Kurachi H; Tasaka K; Murata Y Oncogene; 2004 Jun; 23(26):4505-15. PubMed ID: 15048073 [TBL] [Abstract][Full Text] [Related]
7. Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway. Arai A; Kanda E; Miura O Oncogene; 2002 Apr; 21(17):2641-51. PubMed ID: 11965537 [TBL] [Abstract][Full Text] [Related]
8. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Pozo-Guisado E; Lorenzo-Benayas MJ; Fernández-Salguero PM Int J Cancer; 2004 Mar; 109(2):167-73. PubMed ID: 14750165 [TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K. Sun M; Paciga JE; Feldman RI; Yuan Z; Coppola D; Lu YY; Shelley SA; Nicosia SV; Cheng JQ Cancer Res; 2001 Aug; 61(16):5985-91. PubMed ID: 11507039 [TBL] [Abstract][Full Text] [Related]
10. Mitogenic activity of estrogens in human breast cancer cells does not rely on direct induction of mitogen-activated protein kinase/extracellularly regulated kinase or phosphatidylinositol 3-kinase. Gaben AM; Saucier C; Bedin M; Redeuilh G; Mester J Mol Endocrinol; 2004 Nov; 18(11):2700-13. PubMed ID: 15297603 [TBL] [Abstract][Full Text] [Related]
11. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells. Kimmelman AC; Osada M; Chan AM Oncogene; 2000 Apr; 19(16):2014-22. PubMed ID: 10803462 [TBL] [Abstract][Full Text] [Related]
12. p21ras initiates Rac-1 but not phosphatidyl inositol 3 kinase/PKB, mediated signaling pathways in T lymphocytes. Genot E; Reif K; Beach S; Kramer I; Cantrell D Oncogene; 1998 Oct; 17(13):1731-8. PubMed ID: 9796702 [TBL] [Abstract][Full Text] [Related]
13. Rac is activated by tumor necrosis factor alpha and is involved in activation of Erk. Nosaka Y; Arai A; Kanda E; Akasaki T; Sumimoto H; Miyasaka N; Miura O Biochem Biophys Res Commun; 2001 Jul; 285(3):675-9. PubMed ID: 11453646 [TBL] [Abstract][Full Text] [Related]
14. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling. Varma H; Conrad SE Cancer Res; 2002 Jul; 62(14):3985-91. PubMed ID: 12124331 [TBL] [Abstract][Full Text] [Related]
15. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways. Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206 [TBL] [Abstract][Full Text] [Related]
16. p130Cas regulates the activity of AND-34, a novel Ral, Rap1, and R-Ras guanine nucleotide exchange factor. Gotoh T; Cai D; Tian X; Feig LA; Lerner A J Biol Chem; 2000 Sep; 275(39):30118-23. PubMed ID: 10896938 [TBL] [Abstract][Full Text] [Related]
17. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras. Akagi T; Murata K; Shishido T; Hanafusa H Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282 [TBL] [Abstract][Full Text] [Related]
18. 17 beta-estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells. Guo RX; Wei LH; Tu Z; Sun PM; Wang JL; Zhao D; Li XP; Tang JM J Steroid Biochem Mol Biol; 2006 Apr; 99(1):9-18. PubMed ID: 16567092 [TBL] [Abstract][Full Text] [Related]
19. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Han J; Luby-Phelps K; Das B; Shu X; Xia Y; Mosteller RD; Krishna UM; Falck JR; White MA; Broek D Science; 1998 Jan; 279(5350):558-60. PubMed ID: 9438848 [TBL] [Abstract][Full Text] [Related]
20. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]